Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ TRAK1 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA564938
Description
Immunogen sequence: CTPRRLSLAES FTNTRESTTT MSTSLGLVWL LKERGISAAV YDPQSWDRAG RGSLLHSYTP KMAVIPSTPP NSPMQTPTSS PPSFEFKCTS PPYDNFLASK PASSILREVR EKNVRSSESQ TDVSVSNLNL VD Highest antigen sequence identity to the following orthologs - mouse 95%, rat 95%.
Involved in the regulation of endosome-to-lysosome trafficking, including endocytic trafficking of EGF-EGFR complexes and GABA-A receptors. Involved in mitochondrial motility. When O-glycosylated, abolishes mitochondrial motility. Crucial for recruiting OGT to the mitochondrial surface of neuronal processes. TRAK1 and RHOT form an essential protein complex that links KIF5 to mitochondria for light chain-independent, anterograde transport of mitochondria.
Specifications
TRAK1 | |
Polyclonal | |
Unconjugated | |
TRAK1 | |
106 kDa O-GlcNAc transferase-interacting protein; 2310001H13Rik; AI413908; AI467545; hyrt; KIAA1042; MILT1; milton homolog 1; mKIAA1042; OGT(O-Glc-NAc transferase)-interacting protein 106 KDa; OIP106; O-linked N-acetylglucosamine transferase interacting protein 106; Protein Milton; RGD1307844; trafficking kinesin protein 1; trafficking kinesin-binding protein 1; trafficking protein, kinesin binding 1; TRAK1 | |
Rabbit | |
Antigen Affinity Chromatography | |
RUO | |
22906 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunocytochemistry | |
0.2 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
Q9UPV9 | |
TRAK1 | |
Recombinant Human TRAK1. Recombinant protein control fragment (Product #RP-105720). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction